Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Revenues        
Total revenues $ 18,977 $ 2,189 $ 30,290 $ 5,574
Cost of sales        
Total cost of sales 16,605 10,478 28,505 16,682
Gross profit/(loss) 2,372 (8,289) 1,785 (11,108)
Operating expenses        
Research and development 15,651 9,827 26,509 22,167
Sales and marketing 10,894 2,958 16,343 7,452
General and administrative 13,142 2,964 26,988 5,589
In-process research and development assets acquired 10,400   10,400  
Total operating expenses 50,087 15,749 80,240 35,208
Loss from operations (47,715) (24,038) (78,455) (46,316)
Change in fair value of warrant liability     (56,576)  
Interest expense (51) (51) (125) (155)
Interest and other income, net 268 323 630 901
Loss before income taxes (47,498) (23,766) (134,526) (45,570)
Income tax benefit 4,318 0 32,238 0
Net loss $ (43,180) $ (23,766) $ (102,288) $ (45,570)
Net loss per share-Basic $ (0.17) $ (0.15) $ (0.41) $ (0.29)
Net loss per share-Diluted $ (0.17) $ (0.15) $ (0.41) $ (0.29)
Weighted average shares outstanding basic 255,097,905 158,124,160 246,717,400 157,186,939
Weighted average shares outstanding diluted 255,098,000 158,124,000 246,717,000 157,187,000
Products        
Revenues        
Total revenues $ 17,560 $ 1,531 $ 27,871 $ 4,225
Cost of sales        
Total cost of sales 15,490 9,372 25,977 14,413
Services        
Revenues        
Total revenues 1,417 658 2,419 1,349
Cost of sales        
Total cost of sales $ 1,115 $ 1,106 $ 2,528 $ 2,269